Table 1.
Descriptive statistics for measures at different time points, by reporter, per treatment condition.
| Measure | Time Point | COMB | CBT | SRT | Placebo | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | M | SD | |||
| NASSQ | Baseline | Y | 66.35 | 23.79 | 68.30 | 24.32 | 66.08 | 23.00 | 63.82 | 22.19 |
| NASSQ | Week 12 | Y | 43.56 | 13.77 | 45.31 | 14.10 | 43.04 | 12.71 | 45.25 | 17.39 |
| Coping efficacy | Baseline | Y | 3.07 | 1.41 | 3.25 | 1.45 | 3.32 | 1.36 | 3.15 | 1.39 |
| Coping efficacy | Week 12 | Y | 5.72 | 1.19 | 5.24 | 1.22 | 5.33 | 1.44 | 4.81 | 1.38 |
| Coping efficacy | Baseline | P | 2.39 | 0.97 | 2.56 | 1.18 | 2.66 | 1.10 | 2.73 | 1.28 |
| Coping efficacy | Week 12 | P | 5.57 | 1.07 | 4.91 | 1.21 | 4.98 | 1.45 | 4.24 | 1.26 |
| Anxiety symptoms | Baseline | IE | 19.54 | 3.86 | 19.01 | 4.27 | 18.76 | 4.34 | 19.43 | 4.39 |
| Anxiety symptoms | Week 24 | IE | 6.22 | 5.14 | 8.38 | 6.18 | 8.03 | 6.63 | 11.63 | 6.70 |
Note: NASSQ = Negative Affectivity Self-Statements Questionnaire; Coping efficacy = Coping Questionnaire; COMB = combined treatment; SRT = sertraline; CBT = cognitive-behavioral therapy; Y = Youth; P = Parent; IE = Independent Evaluator; Baseline = Pretreatment; Week 12 = Posttreatment; Week 24 = 3-month follow-up.